Abstract
Patients with systolic heart failure and anemia have worse symptoms, functional capacity, and outcomes than those without anemia. We evaluated the effects of darbepoetin alfa on clinical outcomes in patients with systolic heart failure and anemia.
| Original language | English |
|---|---|
| Journal | The New England journal of medicine |
| Volume | 368 |
| Issue number | 13 |
| Pages (from-to) | 1210-9 |
| Number of pages | 10 |
| ISSN | 0028-4793 |
| DOIs | |
| Publication status | Published - 28 Mar 2013 |
Keywords
- Aged
- Anemia
- Double-Blind Method
- Erythropoietin
- Female
- Heart Failure, Systolic
- Hematinics
- Hemoglobins
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Proportional Hazards Models
- Shock, Septic
- Stroke
- Thromboembolism
- Treatment Failure
Fingerprint
Dive into the research topics of 'Treatment of anemia with darbepoetin alfa in systolic heart failure'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS